Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,427 public trials 3,296 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

NCT05198934

Conditions
Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • Johns Hopkins University School of Medicine Washington D.C., District of Columbia, United States
View all 105 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

NCT04210115

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations
  • MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691) Long Beach, California, United States
  • Columbus Regional Research Institute ( Site 0047) Columbus, Georgia, United States
  • University of Kansas Cancer Center ( Site 0023) Westwood, Kansas, United States
  • Cancer Center of Kansas ( Site 0058) Wichita, Kansas, United States
View all 170 locations
View Trial Details
Completed

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

NCT05512377

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 60 locations
View Trial Details
Completed

Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

NCT03693170

Conditions
BRAF V600E-mutant Metastatic Colorectal Cancer, Colonic Diseases, Colorectal Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • PC dba West Cancer Center Germantown, Tennessee, United States
  • Krankenhaus der Barmherzigen Brüder Vienna, Austria
  • UZ Gent, Gastro-Enterology Ghent, East Flanders, Belgium
View all 45 locations
View Trial Details

Related conditions